Tavalisse 150 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F47UW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,736
Award facts
- Contract value 100% obligated
- $20,735.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20.7K delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 28, 2026, for the supply of Tavalisse 150 mg tablets (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by February 19, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical healthcare solutions provider to federal medical procurement systems.
This delivery order represents a task order issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.9M and extending through December 2026. As the prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Tavalisse delivery demonstrates the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to sustain the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F47UW?
SPE2DR26F47UW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F47UW worth?
The government has obligated $20,736 on SPE2DR26F47UW.
Is contract SPE2DR26F47UW an order under another contract?
Yes. SPE2DR26F47UW is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47UW competed?
The extent of competition for SPE2DR26F47UW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award